• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期N末端B型利钠肽原(NTproBNP)血浆值及其与动脉导管未闭闭合和治疗的关联——一项极早产儿的超声心动图研究

Early N-Terminal Pro B-Type Natriuretic Peptide (NTproBNP) Plasma Values and Associations with Patent Ductus Arteriosus Closure and Treatment-An Echocardiography Study of Extremely Preterm Infants.

作者信息

Gudmundsdottir Anna, Bartocci Marco, Picard Oda, Ekström Joanna, Chakhunashvili Alexander, Bohlin Kajsa, Attner Caroline, Printz Gordana, Karlsson Mathias, Mohlkert Lilly-Ann, Karlén Jonna, Pegelow Halvorsen Cecilia, Edstedt Bonamy Anna-Karin

机构信息

Department of Women's and Children's Health, Karolinska Institutet, 171 77 Stockholm, Sweden.

Department of Neonatology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, 171 64 Stockholm, Sweden.

出版信息

J Clin Med. 2022 Jan 27;11(3):667. doi: 10.3390/jcm11030667.

DOI:10.3390/jcm11030667
PMID:35160119
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8837127/
Abstract

The aim was to investigate the association of gestational age (GA), echocardiographic markers and levels of plasma N-terminal pro-B-type natriuretic peptide (NTproBNP) with the closure rate of a haemodynamically significant patent ductus arteriosus (hsPDA). Ninety-eight Swedish extremely preterm infants, mean GA 25.7 weeks (standard deviation 1.3), born in 2012-2014, were assessed with echocardiography and for levels of NTproBNP. Thirty-three (34%) infants had spontaneous ductal closure within three weeks of age. Infants having spontaneous closure at seven days or less had significantly lower NTproBNP levels on day three, median 1810 ng/L (IQR 1760-6000 ng/L) compared with: infants closing spontaneously later, 10,900 ng/L (6120-19,200 ng/L); infants treated either with ibuprofen only, 14,600 ng/L (7740-28,100 ng/L); or surgery, 32,300 ng/L (29,100-35,000 ng/L). Infants receiving PDA surgery later had significantly higher NTproBNP values on day three than other infants. Day three NTproBNP cut-off values of 15,001-18,000 ng/L, predicted later PDA surgery, with an area under the curve in ROC analysis of 0.69 (0.54-0.83). In conclusion, the spontaneous PDA closure rate is relatively high in extremely preterm infants. Early NTproBNP levels can be used with GA in the management decisions of hsPDA.

摘要

目的是研究胎龄(GA)、超声心动图标志物及血浆N末端B型脑钠肽原(NTproBNP)水平与血流动力学显著的动脉导管未闭(hsPDA)闭合率之间的关联。对98例2012 - 2014年出生的瑞典极早产儿进行了评估,其平均胎龄为25.7周(标准差1.3),接受了超声心动图检查及NTproBNP水平检测。33例(34%)婴儿在3周龄内实现了动脉导管自发闭合。在7天及以内实现自发闭合的婴儿在第3天的NTproBNP水平显著低于:自发闭合较晚的婴儿,为10900 ng/L(6120 - 19200 ng/L);仅接受布洛芬治疗的婴儿,为14600 ng/L(7740 - 28100 ng/L);或接受手术治疗的婴儿,为32300 ng/L(29100 - 35000 ng/L)。接受PDA手术较晚的婴儿在第3天的NTproBNP值显著高于其他婴儿。第3天NTproBNP截断值为15001 - 18000 ng/L时,可预测后期PDA手术,ROC分析曲线下面积为0.69(0.54 - 0.83)。总之,极早产儿中PDA自发闭合率相对较高。早期NTproBNP水平可与胎龄一起用于hsPDA的管理决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d137/8837127/af832bb371bf/jcm-11-00667-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d137/8837127/297f94905be8/jcm-11-00667-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d137/8837127/7599a3fb88ea/jcm-11-00667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d137/8837127/af832bb371bf/jcm-11-00667-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d137/8837127/297f94905be8/jcm-11-00667-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d137/8837127/7599a3fb88ea/jcm-11-00667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d137/8837127/af832bb371bf/jcm-11-00667-g003.jpg

相似文献

1
Early N-Terminal Pro B-Type Natriuretic Peptide (NTproBNP) Plasma Values and Associations with Patent Ductus Arteriosus Closure and Treatment-An Echocardiography Study of Extremely Preterm Infants.早期N末端B型利钠肽原(NTproBNP)血浆值及其与动脉导管未闭闭合和治疗的关联——一项极早产儿的超声心动图研究
J Clin Med. 2022 Jan 27;11(3):667. doi: 10.3390/jcm11030667.
2
Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.影响早产儿 N 端脑利钠肽前体水平的因素及其在动脉导管未闭血流动力学意义判断中的应用。
Eur J Pediatr. 2018 Apr;177(4):521-532. doi: 10.1007/s00431-018-3089-y. Epub 2018 Jan 19.
3
Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants.早期N末端脑钠肽前体测量可预测早产儿临床上显著的动脉导管未闭。
Acta Paediatr. 2009 Aug;98(8):1254-9. doi: 10.1111/j.1651-2227.2009.01315.x. Epub 2009 Apr 30.
4
B-type and N-terminal pro-B-type natriuretic peptides are equally useful in assessing patent ductus arteriosus in very preterm infants.B型利钠肽和N末端B型利钠肽原在评估极早产儿动脉导管未闭方面同样有用。
Acta Paediatr. 2015 Apr;104(4):e139-42. doi: 10.1111/apa.12892. Epub 2015 Feb 4.
5
N-terminal pro-brain natriuretic peptide used for screening hemodynamically significant patent ductus arteriosus in very low birth weight infants: How and when?用于筛查极低出生体重儿血流动力学显著的动脉导管未闭的N末端脑钠肽前体:如何使用及何时使用?
Clin Hemorheol Microcirc. 2020;75(3):335-347. doi: 10.3233/CH-190803.
6
N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.N 端前 B 型利钠肽:动脉导管未闭严重程度的一项指标。
Arch Dis Child Fetal Neonatal Ed. 2008 Jul;93(4):F257-60. doi: 10.1136/adc.2007.120691. Epub 2008 Jan 24.
7
Early haemodynamically significant patent ductus arteriosus does not predict future persistence in extremely preterm infants.早期血流动力学意义显著的动脉导管未闭并不能预测极早产儿未来的持续性。
Acta Paediatr. 2019 Sep;108(9):1590-1596. doi: 10.1111/apa.14752. Epub 2019 Mar 10.
8
Patent ductus arteriosus in preterm infants born at 23-24 weeks' gestation: Should we pay more attention?23-24 周早产儿动脉导管未闭:我们是否应更关注?
Early Hum Dev. 2019 Aug;135:16-22. doi: 10.1016/j.earlhumdev.2019.06.002. Epub 2019 Jun 15.
9
B-type natriuretic Peptide assay for the diagnosis and prognosis of patent ductus arteriosus in preterm infants.B 型利钠肽测定在早产儿动脉导管未闭诊断和预后中的应用。
Korean Circ J. 2012 Mar;42(3):192-6. doi: 10.4070/kcj.2012.42.3.192. Epub 2012 Mar 26.
10
N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants.早产儿的N端脑钠肽前体与动脉导管未闭
J Perinatol. 2009 Feb;29(2):137-42. doi: 10.1038/jp.2008.185. Epub 2008 Nov 20.

引用本文的文献

1
Serum Biomarkers in Patent Ductus Arteriosus in Preterm Infants: A Narrative Review.早产儿动脉导管未闭的血清生物标志物:一项叙述性综述
Biomedicines. 2025 Mar 9;13(3):670. doi: 10.3390/biomedicines13030670.
2
The Changing Complementary Role of Multimodality Imaging in Clinical Cardiology.多模态成像在临床心脏病学中不断变化的辅助作用
J Clin Med. 2022 Nov 30;11(23):7095. doi: 10.3390/jcm11237095.

本文引用的文献

1
Natural evolution of the patent ductus arteriosus in the extremely premature newborn and respiratory outcomes.动脉导管未闭在极早产儿中的自然演变与呼吸结局。
J Perinatol. 2022 May;42(5):642-648. doi: 10.1038/s41372-021-01277-2. Epub 2021 Nov 23.
2
Spontaneous Closure of the Ductus Arteriosus in Preterm Infants: A Systematic Review.早产儿动脉导管的自然闭合:一项系统评价
Front Pediatr. 2020 Sep 11;8:541. doi: 10.3389/fped.2020.00541. eCollection 2020.
3
Defining "Haemodynamic Significance" of the Patent Ductus Arteriosus: Do We Have All the Answers?
动脉导管未闭的血流动力学意义定义:我们是否已经有了所有的答案?
Neonatology. 2020;117(2):225-232. doi: 10.1159/000506988. Epub 2020 May 25.
4
Cardiac Troponin T in Healthy Full-Term Infants.健康足月儿的心肌肌钙蛋白T
Pediatr Cardiol. 2019 Dec;40(8):1645-1654. doi: 10.1007/s00246-019-02199-9. Epub 2019 Sep 5.
5
Effect of patent ductus arteriosus on pulmonary vascular disease.动脉导管未闭对肺血管疾病的影响。
Congenit Heart Dis. 2019 Jan;14(1):37-41. doi: 10.1111/chd.12702.
6
The definition of a hemodynamically significant ductus arteriosus.血流动力学显著的动脉导管的定义。
Pediatr Res. 2019 May;85(6):740-741. doi: 10.1038/s41390-019-0342-7. Epub 2019 Feb 15.
7
Natural evolution of ductus arteriosus with noninterventional conservative management in extremely preterm infants born at 23-28 weeks of gestation.极早早产儿(孕 23-28 周)出生后,采用非介入性保守治疗管理,其动脉导管自然退化。
PLoS One. 2019 Feb 13;14(2):e0212256. doi: 10.1371/journal.pone.0212256. eCollection 2019.
8
Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial).早产儿动脉导管未闭的早期治疗与观察性管理:欧洲一项多中心、随机、非劣效性试验(BeNeDuctus试验)
BMC Pediatr. 2018 Aug 4;18(1):262. doi: 10.1186/s12887-018-1215-7.
9
Early echocardiography does not predict subsequent treatment of symptomatic patent ductus arteriosus in extremely preterm infants.早期超声心动图不能预测极早产儿症状性动脉导管未闭的后续治疗。
Acta Paediatr. 2018 Nov;107(11):1909-1916. doi: 10.1111/apa.14361. Epub 2018 May 11.
10
Treatment and Nontreatment of the Patent Ductus Arteriosus: Identifying Their Roles in Neonatal Morbidity.动脉导管未闭的治疗与非治疗:明确其在新生儿发病中的作用
J Pediatr. 2017 Oct;189:13-17. doi: 10.1016/j.jpeds.2017.06.054. Epub 2017 Jul 11.